Published Date: 10 Mar 2023
Most studies used to examine small amounts of DNA in early human embryos do not involve gene therapy. As a result...
Read Full News1.
Veterans of the Navy have high lung cancer rates associated with asbestos use.
2.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
3.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
1.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment
4.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
4.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation